SEC Form 4 · accession 0001171843-16-008077
AKORN INC · AKRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Lichter
Officer — EVP, Pharmaceutical Operations
Period of report
Feb 19, 2016
Accepted (ET)
Feb 23, 2016 · 9:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000003116
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2,F1 | $24.95 | Feb 19, 2016 | A | 84,000 | A | — | Feb 19, 2023 | Common Stock | 84,000 | 84,000 | D |
Explanation of responses
- F1The Stock Options vest in four equal installments on February 19, 2017, February 19, 2018, February 19, 2019 and February 19, 2020.
- F2There was no consideration given in exchange for the security.